Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group. - Daniel,D.G.; Zimbroff,D.L.; Potkin,S.G. (Neuropsychopharmacology, 1999)